Volume 37, Issue 9 , Pages 741-745, November 2009
Multidrug-resistant Escherichia coli bacteremia in cancer patients
Background
Multidrug-resistant (MDR) Escherichia coli is a serious threat to cancer patients. We aimed to determine the risk factors associated with the development of MDR E coli bacteremia in cancer patients and the possibility of horizontal transmission.
Methods
We conducted a 1:2 case-control study of 58 patients with MDR E coli bacteremia. The patient's demographics, clinical characteristics, and antibiotic use were obtained. MDR E coli was defined as resistant strains to quinolones plus 1 of the following: piperacillin, ceftazidime, or cefepime. Repetitive sequence-based polymerase chain reaction (Rep-PCR) was used to identify DNA interstrain similarities.
Results
Conditional multiple logistic analysis showed that admission to the hospital within the 30 days prior to infection and chemotherapy use were risk factors for infection with MDR E coli. Rep-PCR showed that, among the MDR E coli strains recovered, 48.6% showed >95% similarity, representing a possible clonal outbreak. Infection control measures were implemented and controlled this horizontal transmission.
Conclusion
Prior admission to the hospital and previous chemotherapy were independent risk factors of acquiring MDR E coli. Molecular fingerprinting techniques detected a possible nosocomial clonal outbreak of MDR E coli, which was aborted through infection control measures.
To access this article, please choose from the options below
Supported by discretionary funds, with no external or private financial support. KJV and JAA contributed equally to this work.
An abstract version of this paper was presented at the 45th Annual Meeting of the Infectious Diseases Society of America (IDSA) on October 2007.
Conflicts of interest: None to report.
PII: S0196-6553(09)00429-5
doi:10.1016/j.ajic.2009.02.002
© 2009 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc All rights reserved.
Volume 37, Issue 9 , Pages 741-745, November 2009
